Masatoshi Yokoyama - Concepedia

Author

Masatoshi Yokoyama

Saga University ORCID

Also Known As

M Yokoyama, M. YOKOYAMA, M. Yokoyama, MASATOSHI YOKOYAMA, Masatoshi YOKOYAMA, Masatoshi Yokoyama, Yokoyama, Masatoshi

106

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Saga University Saga Medical School Hospital Tohoku University Memorial University of Newfoundland Niigata University

About

Masatoshi Yokoyama is an author at Saga University specializing in medicine, pathology, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	893
2	Public Health	6	6	261
3	Health Sciences	2	2	138
4	Natural Sciences	1	1	37
5	Allergy	1	1	16

Masatoshi Yokoyama

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation Y. Nakao, Xiaolong Yang, Masatoshi Yokoyama, British Journal of Cancer Tumor BiologyViral ReplicationHuman Papillomavirus VaccinesMalignant TransformationPathology	1997	113
MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion Y. Nakao, Masatoshi Yokoyama, Koichi Hara, Gynecologic Oncology Oncologic ImagingMedical ImagingMyometrial InvasionGynecologyMr Imaging	2006	99
Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A) Tomoyasu Kato, Atsuo Takashima, Takahiro Kasamatsu, Gynecologic Oncology Cervical Cancer ManagementTumoral PathologyCervical CancerMedicineCancer Management	2015	95
The tea polyphenol, (−)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines Masatoshi Yokoyama Gynecologic Oncology Cervical Cell LinesTea PolyphenolMedicineTelomerase ActivityCell Death	2003	82
Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen. Yushi Nishimura, Masatoshi Yokoyama, Kazuo Araki, PubMed Human-mouse Chimeric AntibodyImmunohematologyImmunocytochemical TechniqueImmunologyPathology	1987	80
A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas Yasuko Koyamatsu, Masatoshi Yokoyama, Y. Nakao, Gynecologic Oncology Cervical Cancer ManagementVulvar DiseasesPrecancerous LesionsCervical HealthCervical Cancer	2003	60
Immunopathological Significance of Ovarian Teratoma in Patients with Anti-N-Methyl-<smlcap>D</smlcap>-Aspartate Receptor Encephalitis Emi Tabata, Masanori Masuda, Makoto Eriguchi, European Neurology	2013	50
Inhibitory effect of the tea polyphenol, (−)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines Mitsuyo Noguchi, Masatoshi Yokoyama, Sumiko Watanabe, Cancer Letters Tumor BiologyTea PolyphenolCervical CancerChemoprevention StrategyMedicine	2005	50
Anthropometric and Other Risk Factors for Ovarian Cancer in a Case‐Control Study Mitsuru Mori, Takashi Nishida, Toru Sugiyama, Japanese Journal of Cancer Research	1998	49
A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes Mitsuya Ishikawa, Takahiro Kasamatsu, Hitoshi Tsuda, Gynecologic Oncology Tumoral PathologyCervical CancerMedicineSurgical PathologyNeuroendocrine Disorder	2019	49

Page 1